| Identification | Back Directory | [Name]
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid | [CAS]
1132709-15-9 | [Synonyms]
(1R,2R)-BortezoMib
Bortezomib USP RC A
(1R,2R)-Bortezomib Impurity
Bortizomib RR (Diastereomer)
Bortezomib Diastereomer (R,R)
Boron tezomio enantiomers (RR)
Bortezomib USP Related Compoud H
Bortezomib impurity 1/(1R,2R)-Bortezomib
N-(2-Pyrazinecarbonyl)-D-phenylalanine-L-leucine boronic anhydride
Bortezomib Related Compound A/ Bortezomib Impurity D (Bortezomib R,R-Isomer Impurity)
((R)-3-Methyl-1-((R)-3-phenyl-2-(pyrazine-2-carboxaMido)propanaMido)butyl)boronic acid
[(1R)-3-methyl-1-[[(2R)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
Boronic acid, B-[(1R)-3-methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
Bortezomib 1R, 2R IsomerQ: What is
Bortezomib 1R, 2R Isomer Q: What is the CAS Number of
Bortezomib 1R, 2R Isomer Q: What is the storage condition of
Bortezomib 1R, 2R Isomer Q: What are the applications of
Bortezomib 1R, 2R Isomer | [Molecular Formula]
C19H25BN4O4 | [MDL Number]
MFCD26940312 | [MOL File]
1132709-15-9.mol | [Molecular Weight]
384.24 |
| Chemical Properties | Back Directory | [density ]
1.214±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2-8°C | [solubility ]
Chloroform (Slightly), DMSO (Slightly, Heated), Methanol (Slightly) | [form ]
Solid | [pka]
9.66±0.43(Predicted) | [color ]
White to Off-White | [InChIKey]
GXJABQQUPOEUTA-WBVHZDCISA-N | [SMILES]
B([C@@H](NC(=O)[C@H](NC(C1=NC=CN=C1)=O)CC1=CC=CC=C1)CC(C)C)(O)O |
| Hazard Information | Back Directory | [Uses]
(1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway |
|
| Company Name: |
OPULENT PHARMA
|
| Tel: |
+91-9106692785 +91-9106692785 |
| Website: |
www.www.NOWEBSITE |
|